Elemental Calcium

DIETARY_SUPPLEMENT4 trials

Sponsors

Organon and Co, Yale University, GlaxoSmithKline, mAbxience Research S.L.

Conditions

Osteoporosis, PostmenopausalPolycystic Ovarian SyndromePostmenopausal OsteoporosisPostmenopausal Women With OsteoporosisVitamin D Deficiency

Phase 3

A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)

CompletedNCT00092014

Organon and CoPostmenopausal Osteoporosis

Start: 2002-09-01End: 2004-04-01Updated: 2024-08-14

Denosumab China Phase III Study

CompletedNCT02014467

GlaxoSmithKlineOsteoporosis, Postmenopausal

Start: 2014-01-31End: 2015-08-31Updated: 2016-10-31

A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis.

CompletedNCT05338086

mAbxience Research S.L.Postmenopausal Women With Osteoporosis

Start: 2022-03-16End: 2024-05-22Updated: 2025-03-21

Unknown Phase

Health Benefits of Vitamin D and Calcium in Women With PCOS (Polycystic Ovarian Syndrome)

CompletedNCT00743574

Yale UniversityPolycystic Ovarian Syndrome, Vitamin D Deficiency

Start: 2008-08-31End: 2013-02-28Updated: 2021-08-13

Related Papers

Phase III Study to Confirm Clinical Similarity of MB09, a Denosumab Biosimilar, and Prolia® in Postmenopausal Women with Osteoporosis (SIMBA Study)

Pharmaceutics2026-02-27

Pharmacokinetics, pharmacodynamics, safety, and tolerability of single-dose denosumab in healthy Chinese volunteers: A randomized, single-blind, placebo-controlled study

PLoS ONE2018-06-2240 citations